TEVA Teva Pharmaceutical Industries Limited
Healthcare$34.70+0.00%OpenMarket Cap: $40.41B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$39.29
Target (Median)
$40.00
Target Range
$35.00 - $42.00
Upside from current price: 13.2%
Rating Distribution
4 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Barclays | maintain | Overweight | Overweight |
| 2026-04-30 | JP Morgan | maintain | Overweight | Overweight |
| 2026-04-30 | Truist Securities | maintain | Buy | Buy |
| 2026-04-30 | UBS | maintain | Buy | Buy |
| 2026-04-30 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-09 | B of A Securities | maintain | Buy | Buy |
| 2026-03-04 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-18 | Truist Securities | maintain | Buy | Buy |
| 2026-02-09 | Goldman Sachs | maintain | Buy | Buy |
| 2026-01-30 | Barclays | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $3.10 | $17.24B | 8 |
| Sun Dec 31 | $3.43 | $17.97B | 3 |
| Mon Dec 31 | $3.73 | $18.35B | 1 |
| Tue Dec 31 | $4.24 | $19.18B | 1 |